Amgen invests $900M to expand Ohio biomanufacturing
Amgen is the latest in a series of biopharma companies to announce a massive new US-based investment in manufacturing in response to the Trump administration's call to bring pharma manufacturing to the US. The California ...
Amgen is the latest in a series of biopharma companies to announce a massive new US-based investment in manufacturing in response to the Trump administration's call to bring pharma manufacturing to the US.
The California ...
